Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ever tried locating Canopy Growth’s biological asset valuations or U.S. THC exposure in a 300-page report? The company’s cannabis regulations, fair-value accounting and brand acquisitions make each disclosure dense. That’s why this page does more than list documents—it turns the tough parts of Canopy Growth SEC filings explained simply.
Every form—whether a Canopy Growth quarterly earnings report 10-Q filing or a sudden Canopy Growth 8-K material events explained—arrives here within seconds of hitting EDGAR. Stock Titan’s AI instantly produces plain-English summaries, highlights cash-flow turning points and links note references so you can move from headline to footnote without scrolling hundreds of pages. Need to monitor management moves? Our alert engine captures Canopy Growth Form 4 insider transactions real-time, flagging each Canopy Growth executive stock transactions Form 4 alongside price and option data.
Use the annual report to see cultivation capacity; the proxy to unpack Canopy Growth proxy statement executive compensation; or dive into segment margins with our Canopy Growth earnings report filing analysis. If you are tracking regulatory risk, the system groups risk-factor language across years so understanding Canopy Growth SEC documents with AI becomes a two-minute task. Investors, analysts and portfolio managers rely on these tools to answer questions like “What did management say about U.S. legalization timing?” or “Were there new goodwill impairments?”—all without manual page hunts. From the first Canopy Growth insider trading Form 4 transactions alert to a fully indexed Canopy Growth annual report 10-K simplified, every disclosure is refined for faster, smarter decision-making.
Canopy Growth (CGC) disclosed an insider equity grant on a Form 4. A director received 42,658 restricted stock units (RSUs) on November 11, 2025 at a price of $0, reflecting a non-cash award.
The filing notes a staggered vesting schedule: 20,158 RSUs vest on December 31, 2025 and 22,500 RSUs vest on March 31, 2026. Following the grant, the director reported 42,658 shares beneficially owned, held directly. This is routine equity compensation and does not involve cash proceeds.
Canopy Growth Corporation furnished an update on its business by announcing fiscal second-quarter results for the period ended September 30, 2025. The company reported these results via a press release.
The press release was attached as Exhibit 99.1 and furnished under Item 2.02 (Results of Operations and Financial Condition). The company noted this information is furnished, not filed, under the Exchange Act.
Canopy Growth Corporation reported improved quarterly results for the three months ended September 30, 2025. Revenue was CDN$82.998M and net revenue was CDN$66.683M, up from CDN$62.991M a year ago. Gross margin was CDN$21.905M, and the operating loss narrowed to CDN$16.894M from CDN$45.943M. Other income was CDN$15.469M versus an expense last year, resulting in a small net loss from continuing operations of CDN$1.639M, or CDN$0.01 per share, compared with a loss of CDN$1.52 per share a year earlier.
Liquidity strengthened: cash and cash equivalents rose to CDN$298.058M from CDN$113.811M at March 31, 2025, and long‑term debt decreased to CDN$226.333M from CDN$299.811M. Total shareholders’ equity increased to CDN$736.013M. Management states that, given cash on hand, a current portion of long‑term debt of CDN$1.847M, financing actions, and projected cash flows, the company has sufficient liquidity, resolving conditions that previously raised substantial doubt about continuing as a going concern. As of November 6, 2025, there were 342,195,956 common shares outstanding, plus 26,261,474 exchangeable shares convertible one‑for‑one into common shares.
Canopy Growth Corp (CGC) reported an insider update: a director filed a Form 3 initial statement of beneficial ownership. The filing states that no securities are beneficially owned as of the event date 10/10/2025.
The submission was filed by one reporting person and includes an Exhibit 24 Power of Attorney authorizing the signatory.
Canopy Growth Corporation reported the final voting results from its 2025 Annual General and Special Meeting. Shareholders approved a share consolidation authorization, allowing the Board to set a consolidation ratio between 1-for-5 and 1-for-15 for common and exchangeable shares at any time prior to September 26, 2026. A total of 79,971,625 shares were represented out of 239,849,225 entitled to vote.
All five director nominees were elected. Shareholders approved the appointment of PKF O’Connor Davies, LLP as auditor for the fiscal year ending March 31, 2026. The advisory vote on executive compensation also passed.
Key tallies: the share consolidation resolution received 62,742,664 votes for, 16,557,315 against, and 671,647 abstentions; the auditor appointment received 75,518,055 votes for and 4,453,570 withheld.
David Angelo Lazzarato, a director of Canopy Growth Corp (CGC), reported a sale of 15,677 common shares on 09/29/2025 at a price of $1.58 per share. After the sale, he beneficially owned 103,387 shares directly. The filing states the shares disposed were originally granted as restricted stock units on June 3, 2025 and were sold to satisfy tax obligations arising from RSU vesting. The Form 4 was signed on behalf of Mr. Lazzarato by an attorney-in-fact on 09/30/2025. The filing is a routine Section 16 disclosure of an insider transaction related to tax withholding at vesting.
Canopy Growth director Margaret Shan Atkins reported a disposition of common shares tied to vested restricted stock units. On 09/29/2025 the reporting person disposed of 2,216 common shares at $1.58 per share to satisfy tax obligations arising from RSUs granted on 08/12/2025. After the reported transaction the reporting person beneficially owned 43,464 common shares, held directly. The Form 4 indicates the sale is associated with tax withholding on vested equity rather than a separate open-market trading decision.
Theresa Yanofsky, a director of Canopy Growth Corp (CGC), reported a sale of common shares tied to vested restricted stock units. The Form 4 shows a transaction dated 09/29/2025 in which 10,408 common shares were disposed at a price of $1.58 per share, leaving the reporting person with 73,952 shares beneficially owned. The filing explains these shares were originally granted as restricted stock units on June 3, 2025, and the disposition is associated with the reporting person’s tax obligations arising from RSU vesting. The Form 4 was signed by an attorney-in-fact on 09/30/2025.
Canopy Growth Corp (CGC) director Willy Kruh reported the sale of 10,451 common shares on 09/29/2025 at $1.58 per share, leaving him with 62,939 shares beneficially owned. The Form 4 states the shares sold were previously granted as restricted stock units on June 3, 2025, and the sale was made to satisfy tax obligations arising from vesting. The filing is signed by an attorney-in-fact on behalf of the reporting person on 09/30/2025. The report is a single-person Form 4 disclosure and identifies the reporting person as a director.
Canopy Growth Corp director and Chief Executive Officer Luc Mongeau (reporting person) acquired 27,469 common shares on 09/22/2025 at a price of CA$1.82 per share, as reported on Form 4. Following the transaction, Mongeau beneficially owned 812,368 common shares. The Form 4 was signed by an attorney-in-fact on behalf of Mongeau on 09/23/2025. The filing notes that the price is expressed in Canadian dollars. No derivative transactions or additional details were reported.
FAQ
What is the current stock price of Canopy Growth (CGC)?
What is the market cap of Canopy Growth (CGC)?
